Tuesday, February 9, 2016 Last update: 2:33 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

EnteroMedics

News articles for EnteroMedics:

Tuesday, June 17, 2014

Wednesday, April 30, 2014

  • EnteroMedics Reports First Quarter 2014 Financial Results
    ST. PAUL, MN -- (Marketwired) -- 04/30/14 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial results for the three months ended March 31, 2014. For the three months ended March 31, 2014, the ... read more

Wednesday, April 23, 2014

Wednesday, April 9, 2014

  • EnteroMedics Inc. Appoints Mark Bullivant as Vice President of Marketing
    ST PAUL, MN -- (Marketwired) -- 04/09/14 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, is pleased to announced that Mark Bullivant has joined the organization as Vice President of Marketing. He will report to ... read more

Monday, March 10, 2014

Tuesday, February 25, 2014

Wednesday, February 12, 2014

Tuesday, December 3, 2013

  • EnteroMedics Announces 18 Month ReCharge Study Results
    ST. PAUL, MN -- (Marketwired) -- 12/03/13 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced 18 month efficacy and safety results from its 5 year ReCharge Pivotal Trial of VBLOC® vagal blocking therapy ... read more

Monday, November 4, 2013

Thursday, October 31, 2013

  • EnteroMedics Reports Third Quarter 2013 Financial Results
    ST. PAUL, MN -- (Marketwired) -- 10/31/13 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced financial results for the three and nine months ended September 30, 2013. For the three months ended September 30, ... read more

Thursday, October 17, 2013

Tuesday, September 24, 2013

Monday, September 16, 2013

  • EnteroMedics to Present at the Craig-Hallum 4th Annual Alpha Select Conference
    ST. PAUL, MN -- (Marketwired) -- 09/16/13 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Greg S. Lea, EnteroMedics' Chief Financial Officer and Chief Operating Officer, is scheduled to present at the ... read more

Thursday, August 8, 2013

  • EnteroMedics to Present at the Canaccord Genuity 33rd Annual Growth Conference
    ST. PAUL, MN -- (Marketwired) -- 08/08/13 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that Mark B. Knudson, Ph.D., EnteroMedics' President and Chief Executive Officer, is scheduled to present at the Canaccord ... read more

Friday, July 26, 2013

Thursday, July 25, 2013

Tuesday, June 25, 2013

Wednesday, May 22, 2013

Friday, May 17, 2013

  • EnteroMedics Completes VBLOC Therapy Pre-PMA Meeting With FDA
    ST. PAUL, MN -- (Marketwired) -- 05/17/13 -- EnteroMedics Inc. (NASDAQ: ETRM), the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that the Company completed a pre-PMA (Premarket Approval) application meeting with the U.S. Food and Drug Administration (FDA) ... read more